Atorvastatin improves plaque stability in diabetic atherosclerosis through the RAGE pathway
1Department of Neurology, The Third Affiliated Hospital of Nanchang University, Nanchang, China. wuxm79@163.com.
Objective:
To study the improving effect of atorvastatin on plaque stability in diabetes mellitus (DM) mice complicated with atherosclerosis.
Materials And Methods:
Apolipoprotein E (ApoE)-/- mice were used to establish the DM mouse model. Half of the mice received atorvastatin after successful modeling. ApoE-/- and C57BL/6J mice were used as controls. Oil red O staining and Masson staining were performed to detect the lipid and collagen components in mice. Immunohistochemical assay was used to observe the expressions of smooth muscle cell (SMC) and Ly-6c. The expressions of receptor for advanced glycation end products (RAGE), monocyte chemoattractant protein-1 (MCP-1) and nuclear factor-κB (NF-κB) in tissues were detected by Western blotting. Finally, the levels of serum soluble RAGE (sRAGE), advanced glycation end products (AGEs), malondialdehyde (MDA) and reduced glutathione (GSH) in mice were also detected.
Results:
Atorvastatin reduced the area of atherosclerotic plaque and improved the stability of arterial plaque through reducing lipid deposition, the number of macrophages and SMC, increasing collagen fibers. In mice in atorvastatin group, the levels of serum AGEs and sRAGE were decreased. Moreover, atorvastatin inhibited the downstream pathway of RAGE as well as DM, thus inducing the oxidative stress.
Conclusions:
Atorvastatin improves plaque stability in diabetic atherosclerosis through the RAGE pathway.
Insights
Atorvastatin enhances plaque stability in diabetic atherosclerosis by reducing lipid deposition and inflammation. This study shows atorvastatin improves arterial health via the receptor for advanced glycation end products (RAGE) pathway.
Area of Science:
- Cardiovascular Research
- Diabetes Mellitus Research
- Pharmacology
Background:
- Diabetes mellitus (DM) significantly increases the risk of atherosclerosis.
- Diabetic atherosclerosis is characterized by plaque instability, lipid deposition, and inflammation.
- Atorvastatin is a statin drug with potential pleiotropic effects beyond lipid lowering.
Purpose of the Study:
- To investigate the therapeutic effects of atorvastatin on atherosclerotic plaque stability in a mouse model of diabetes mellitus.
- To elucidate the underlying mechanisms by which atorvastatin influences plaque composition and stability in diabetic atherosclerosis.
Main Methods:
- Apolipoprotein E knockout mice were used to establish a combined model of diabetes mellitus and atherosclerosis.
- Histological analyses (Oil red O, Masson staining) were performed to assess lipid and collagen content.
- Immunohistochemistry and Western blotting were employed to evaluate protein expression, including smooth muscle cells, macrophages, RAGE, MCP-1, and NF-κB.
- Serum biomarkers such as AGEs, sRAGE, MDA, and GSH were measured.
Main Results:
- Atorvastatin treatment significantly reduced atherosclerotic plaque area and improved plaque stability.
- Key improvements included decreased lipid deposition, reduced macrophage and smooth muscle cell infiltration, and increased collagen content.
- Atorvastatin administration led to decreased serum levels of advanced glycation end products (AGEs) and soluble receptor for advanced glycation end products (sRAGE).
- The drug inhibited the RAGE signaling pathway and reduced oxidative stress markers.
Conclusions:
- Atorvastatin effectively improves plaque stability in the context of diabetic atherosclerosis.
- The beneficial effects are mediated, at least in part, through modulation of the receptor for advanced glycation end products (RAGE) pathway.
- Atorvastatin's action involves reducing lipid accumulation, inflammation, and oxidative stress, thereby stabilizing atherosclerotic lesions.
Related Concept Videos
Atherosclerosis III: Management
Atherosclerosis I: Introduction
mRNA Stability and Gene Expression
Cis-acting Elements involved in mRNA stability
Nuclear Stability
To hold positively charged protons together...
RNA Stability
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...


